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Increased muscle loading results in the phosphorylation of the 70 kDa ribosomal S6 kinase (p70S6k), and this event is strongly
correlated with the degree of muscle adaptation following resistance exercise. Whether insulin resistance or the comorbidities
associated with this disorder may affect the ability of skeletal muscle to activate p70S6k signaling following an exercise stimulus
remains unclear. Here, we compare the contraction-induced activation of p70S6k signaling in the plantaris muscles of lean and
insulin resistant obese Zucker rats following a single bout of increased contractile loading. Compared to lean animals, the basal
phosphorylation of p70S6k (Thr389; 37.2% and Thr421/Ser424; 101.4%), Akt (Thr308; 25.1%), and mTOR (Ser2448; 63.0%) was
higher in obese animals. Contraction increased the phosphorylation of p70S6k (Thr389), Akt (Ser473), and mTOR (Ser2448) in
both models however the magnitude and kinetics of activation differed between models. These results suggest that contraction-
induced activation of p70S6k signaling is altered in the muscle of the insulin resistant obese Zucker rat.
Copyright © 2009 Anjaiah Katta et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Insulin resistance is an important health concern that is
rapidly increasing worldwide. If allowed to precede unche-
cked, insulin resistance often leads to increased morbidity
and mortality. Anaerobic exercise has recently been recog-
nized to be of potential benefit for the treatment of this
condition [1–4], as progressive resistance training has been
found to improve glycemic control, increase skeletal muscle
size and strength, while also decreasing visceral and total
body fat [5–7]. Whether insulin resistance affects how muscle
responds to resistance training is unknown, but the existence
of differences, if present, may help to explain why exercise-
induced skeletal muscle adaptations may differ between
normal and diabetic muscle [8–10].
Recent in vitro and in vivo studies have suggested that
increased muscle loading correlates with increases in the
rates of accumulation and synthesis of muscle protein [11–
14]. This increase in protein synthesis, at least in part, is
thought to be regulated by the phosphorylation of the p70
ribosomal protein S6 kinase (p70S6k) [11, 15, 16] and the
mammalian target of rapamycin (mTOR) which functions
as a growth factor and nutrient-sensing signaling molecule
in mammalian cells [17]. How mTOR activity is modu-
lated is not entirely clear; however previous studies have
reported that resistance exercise increases mTOR activity via
an upstream pathway involving phosphoinositide 3-kinase
(PI3K) and protein kinase B (PKB)/Akt [15, 18, 19]. Other
work has suggested that the activity of PI3K/Akt signaling
pathway can be negatively regulated by the phosphatase and
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tensin homologue deleted on chromosome 10 (PTEN) [20].
How the activity of these pathways are regulated following
increased muscle contraction and if insulin resistance affects
these processes are not well understood.
The purpose of this study was to determine whether
exercise-induced p70S6k signaling is altered in the skeletal
muscle of the insulin resistant obese Zucker rat. We hypoth-
esized that contraction-induced p70S6k signaling would
differ between normal and insulin resistant muscle. To test
this hypothesis, the activation of p70S6k and its pathway
related proteins mTOR, Akt, and PTEN were assessed in
the plantaris muscles of normal and insulin resistance rats
either immediately after or during the recovery phase of
an acute bout of high-frequency electrical stimulation. Our
findings suggest that insulin resistance or the co-morbidities
associated with this disorder may affect how muscle regulates
contractile-induced signaling.
2. Materials and Methods
2.1. Animal Care. All procedures were performed as outlined
in the Guide for the Care and Use of Laboratory Animals
as approved by the Council of the American Physiological
Society and the institutional animal use review board. Young
(10 week, n= 12) male Lean Normal Zucker (LNZ) and
young (10 week, n= 12) male Obese Syndrome-X Zucker
(OSXZ) rats were obtained from the Charles River Laborato-
ries. Rats were housed two to a cage in an AAALAC approved
vivarium. Housing conditions consisted of a 12 H: 12 H dark-
light cycle and temperature was maintained at 22◦±2◦C. Ani-
mals were provided food and water ad libitum and allowed
to recover from shipment for at least two weeks before
experimentation. During this time the animals were carefully
observed and weighed weekly to ensure none exhibited signs
of failure to thrive, such as precipitous weight loss, disinterest
in the environment, or unexpected gait alterations.
2.2. Materials. Anti-p70S6k (#9202), Akt (#9272), mTOR
(#2972), glycogen synthase kinase-3β (GSK-3β) (#9332),
PTEN (#9552), Thr389 (#9206) and Ser 421 / Thr 424
(#9204) phosphorylated p70S6K, Thr308 (#9275) and
Ser473 (#9271) phosphorylated Akt, Ser2448 phosphory-
lated mTOR (#2971), Ser 9 phosphorylated GSK-3β (#9336),
Ser 380/Thr 382/383 phosphorylated PTEN (#9554), Mouse
IgG, and Rabbit IgG antibodies were purchased from Cell
Signaling Technology (Beverly, MA). Enhanced chemilumi-
nescence (ECL) western blotting detection reagent was from
Amersham Biosciences (Piscataway, NJ). Restore western
blot stripping buffer was obtained from Pierce (Rockford,
IL) and 3T3 cell lysates were from Santa Cruz Biotechnology
(Santa Cruz, CA). All other chemicals were purchased from
Sigma (St. Louis, MO) or Fisher Scientific (Hanover, IL).
2.3. Contractile Stimulation of Skeletal Muscles. The high-
frequency electrical stimulation (HFES) model has been
previously described [21] and was chosen on the basis of
its efficacy in stimulating protein translation and muscle
hypertrophy in vivo [11]. The HFES model used in the
present study produced 10 sets of 6 contractions with an
overall protocol time of 22 minutes. This protocol results
in concentric (shortening) contraction of the plantaris and
soleus and eccentric (lengthening) contraction of the EDL
and TA. Animals were killed by a lethal dose of pentobarbital
sodium at baseline, immediately following, 1 or 3 hours
after HFES. Once excised, muscles were blotted dry, trimmed
of visible fat and tendon projections, weighed, immediately
frozen in liquid nitrogen, and stored at −80◦C.
2.4. Preparation of Protein Isolates and Immunoblotting.
Plantaris muscles were pulverized in liquid nitrogen using a
mortar and pestle until a fine powder was obtained. After
washing with ice cold PBS, pellets were lysed on ice in
for 15 minutes in T-PER lysis buffer composed of T-PER
reagent (2 mL/g tissue weight) (Pierce, Rockford, IL), 1 mM
ethylene-diamine tetraacetic acid (EDTA; pH 8.0), 1 mM
ethylene-glycol tetraacetic acid (EGTA; pH 7.5), 1 mM mag-
nesium chloride, phenylmethane sulfonylfluoride (PMSF),
1 μL protease inhibitor cocktail, and 1 mM sodium vanadate
to inhibit phosphatase activity, and then centrifuged for
10 minutes at 2000 g to pellet particulate matter. This
process was repeated twice and the supernants combined
for protein concentration determination using the Bradford
method (Pierce, Rockford, IL). Samples were diluted to
a concentration of 3 μg/μL in SDS loading buffer, boiled
for 5 minutes, and 60 μg of protein were separated using
10% SDS-PAGE gels. Transfer of protein onto nitrocellulose
membranes, verification of transfer, and determination of
equal loading between lanes and membranes was determined
as outlined previously [22]. Protein immunodetection was
performed as outlined by the antibody manufacturer while
immunoreactive bands were visualized with ECL (Amer-
sham Biosciences). Exposure time was adjusted to keep the
integrated optical densities within a linear and nonsaturated
range. Band signal intensity was normalized to β-actin by
densitometry using a flatbed scanner (Epson Perfection 3200
PHOTO) and Imaging software (AlphaEaseFC). Molecular
weight markers (Cell Signaling) were used as molecular mass
standards and NIH 3T3 cell lysates were included as positive
controls. To allow direct comparisons to be made between
the concentration levels of different signaling molecules,
immunoblots were stripped and reprobed with Restore
western blot stripping buffer as detailed by the manufacturer
(Pierce, Rockford, IL).
2.5. Statistical Analysis. Results are presented as mean ±
SEM. Data were analyzed by using the Sigma Stat 3.0 sta-
tistical program. The effects of insulin resistance on protein
phosphorylation were analyzed using a two-way ANOVA
followed by the Student-Newman-Keuls post-hoc testing
when appropriate. Differences were considered significant at
P < .05.
3. Results
Average body mass of the obese Zucker rats was 82.0%
higher (597 ± 21.7 gm versus 328 ± 12.2 gm) than their lean
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Figure 1: Plantaris muscles from lean Zuckers (LNZ) and obese
Zuckers (OSXZ) were analyzed by Western blot analysis for insulin
resistance-related changes in total p70S6k, mTOR, Akt, GSK-3β
and PTEN protein expression. Protein quantification was done after
normalization by the abundance of β-actin. An asterisk (∗) indicates
significant differences (P < .05) from the lean Zucker value.
counterparts (P < .05). Plantaris muscle mass in the obese
Zucker rat expressed as a percentage of body weight was
35.9% less than that (0.41 ± 0.01 versus 1.14 ± 0.04 mg/gm)
seen in the lean Zucker rat (P < .05).
3.1. Akt-p70S6k Pathway Protein Expression and Level of
Basal Phosphorylation is Altered in the Skeletal Muscle of the
Obese Zucker Rat. Immunoblotting analysis demonstrated
that the expression levels of p70S6k and GSK-3β were
∼10% and ∼12% higher in the obese Zucker plantaris
compared to muscles obtained from the lean Zucker (P
< .05) (Figure 1). There were not significant differences in
Akt, mTOR or PTEN protein content (Figure 1). As p70S6k,
mTOR, Akt, GSK-3β, and PTEN are thought to be regulated
by phosphorylation; it was of interest to determine if the
basal phosphorylation status of these proteins is altered with
insulin resistance. Immunoblotting using phospho-specific
antibodies indicated that, the basal level phosphorylation of
p70S6k (Thr389) and p70S6k (Thr421/Ser424) was 37.2%
and 101.4% higher, respectively, in the obese Zucker plantaris
(P < .05) (Figure 2). Similarly, the basal level phosphory-
lation of mTOR (Ser 2448), Akt (Ser 308), GSK-3β (Ser
9), and PTEN (Ser 380/Thr 382/383) was 63.0%, 25.1%,
17.5% and 31.4% higher, respectively, with insulin resistance
(P < .05) (Figures 3–6). Akt (Ser473) phosphorylation was
not different with insulin resistance (Figure 4).
3.2. Regulation of Akt-p70S6k Signaling in Response to a
Contractile Stimulus Is Altered in the Skeletal Muscle of the
Obese Zucker Rat. Phosphorylation of p70S6k, mTOR, Akt,
PTEN, and GSK-3β in exercised plantaris muscles was deter-
mined at 0, 1, and 3 hours after a bout of HFES and com-
pared with control (unstimulated) muscles. Contraction-
induced phosphorylation of these molecules was compared
between lean and obese Zucker rats. In the case of each
molecule examined, significant differences existed between
lean and obese Zucker rat models (Figures 2–6). In the
lean Zucker, p70S6k (Thr389) phosphorylation increased
112.8%, 130.0%, and 96.2% while the phosphorylation of
p70S6k (Thr 421/Ser424) increased 429.8%, 354.5%, and
319.2% at 0, 1, and 3 hour post exercise respectively
(P < .05). In the obese Zucker, HFES increased p70S6k
(Thr389) phosphorylation 79.9%, 43.6% and 104.5% and
the phosphorylation of p70S6k (Thr 421/Ser 424) by 158.9%,
127.8%, and 238.6% at 0, 1, and 3 hours post exercise,
respectively, (P < .05) (Figure 2). In the lean Zucker animals,
the phosphorylation level of mTOR (Ser2448) was increased
121.7%, 115.5%, and 113.8%, from baseline at 0, 1 and 3
hours postexercise, respectively (P < .05) (Figure 3) whereas
mTOR (Ser 2448) phosphorylation in the obese animals was
increased by 51.8%, 47.4%, and 24.5% during the same time
periods (P < .05) (Figure 3).
Lean animals increased the phosphorylation of Akt
(Thr308) by 59.9% and 40.8% immediately after and 1 hour
post exercise while Akt (Ser473) was increased by 109.9%,
23.7%, and 105.9% at 0, 1, and 3 hours post exercise,
respectively, (P < .05) (Figure 4). Conversely, in the obese
animals, Akt (Thr308) phoshorylation was decreased by
21.5%, 18.8%, and 15.3% at 0, 1, and 3 hours post exercise
while the phosphorylation of Akt (Ser473) was increased by
81.8% and 140.9% at 0, and 3 hours post exercise (P < .05)
(Figure 4).
Confirming these differences in Akt phosphorylation,
HFES increased GSK-3β (Ser 9) phosphorylation in the
lean animals by 36.9%, 30.4%, and 23.4% at 0, 1, and
3 hours post exercise (P < .05) (Figure 5). GSK-3β (Ser 9)
phosphorylation did not change with contraction in the
obese plantaris. In lean animals, PTEN (Ser380/Thr382/383)
phosphorylation was increased 23.1% at 3 hours post
exercise while conversely, in the obese Zucker animals, PTEN
phosphorylation decreased by 18.3%, 23.0%, and 13.1% at 0,
1 and 3 hours post exercise, respectively (P < .05) (Figure 6).
4. Discussion
The obese Zucker (fa/fa) rat is a well-established animal
model of skeletal muscle insulin resistance that is character-
ized by marked hyperinsulinemia, glucose intolerance, dys-
lipidemia, and central adiposity. Recent data has suggested
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Figure 2: Contraction-induced p70S6k phosphorylation is altered
with insulin resistance. The basal (control) and contraction-
induced phosphorylation of the p70S6k in Plantaris muscles from
lean (LNZ) and obese (OSXZ) Zucker rats at 0, 1, and 3 hours after
contractile stimulus. p70S6k (Thr389 & Thr421/Ser424) phospho-
rylation was determined by immunoblotting for phosphorylation
on Thr389 and Thr421/Ser424. Relative abundance represents ratio
of phospho to total protein. An asterisk (∗) indicates significant
difference (P < .05) from the control animals and a dagger (†)
indicates a significant difference (P < .05) from the corresponding
time points across animal models.
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Figure 3: Contraction-induced mTOR (Ser 2448) phosphorylation
is altered with insulin resistace. The basal (control) and contraction-
induced phosphorylation of the mTOR in Plantaris muscles from
lean (LNZ) and obese (OSXZ) Zucker rats at 0, 1, and 3-
hours after HFES. Phosphorylation of mTOR was determined by
immunoblotting for phosphorylation on Ser2448. Relative abun-
dance represents ratio of phosphor to total protein. An asterisk (∗)
indicates significant difference (P < .05) from the control animals
and a dagger (†) indicates significant difference (P < .05) from
corresponding time points across the animal models.
that normal and insulin resistant muscle may differ in their
adaptation to an exercise regimen [1, 8, 10, 23–25]. The
molecular mechanism(s) responsible for these differences
have not been widely studied. Here we examine if the
contractile-induced muscle signaling altered in the obese
Zucker rat. Taken together, our data suggests that insulin
resistance may be associated with differences in how skeletal
muscle regulates Akt-p70S6k signaling following an acute
bout of high intensity muscle contraction.
4.1. Insulin Resistance Muscle Is Associated with Alterations
in Akt Pathway Protein Content and Basal Phosphorylation.
Similar to previous work using obese rats [26] and mice [27],
we demonstrate that insulin resistant muscle is associated
with differences in how the p70S6k signaling pathway is
regulated. Specifically, we found that the basal phospho-
rylation level of p70S6k, mTOR, Akt, and GSK-3β was
higher in the insulin resistant plantaris muscles of obese rats
compared to that found in their lean counterparts (Figures
2–5). Previous data has suggested that hyperinsulinemia
and/or hyperglycemia may be associated with increased Akt
Experimental Diabetes Research 5
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Figure 4: Effects of concentric, maximal muscle contraction in situ
on phosphorylation of Akt (Thr308/Ser473). The basal (control)
and contraction-induced phosphorylation of the Akt in Plantaris
muscles from lean (LNZ) and obese (OSXZ) Zucker rats at 0, 1,
and 3 hours after HFES. Akt phosphorylation was determined by
immunoblotting for Akt phosphorylation on Thr308 and Ser473.
Relative abundance represents ratio of phosphor to total protein.
An asterisk (∗) indicates significant difference (P < .05) from the
control n animals, and a dagger (†) indicates significant difference
(P < .05) from corresponding time points across the animal models.
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Figure 5: Contraction-induced GSK-3β (Ser 9) phosphorylation is
altered with insulin resistance. The basal (control) and contraction-
induced phosphorylation of the GSK-3β in Plantaris muscles
from lean (LNZ) and obese (OSXZ) Zucker rats at 0-, 1-, and
3-hours after HFES. Phosphorylation of GSK-3β was determined by
immunodetection of phosphorylation on Ser 9. Relative abundance
represents ratio of phosphor to total protein. An asterisk (∗)
indicates significant difference (P < .05) from the control animals,
and a dagger (†) indicates significant difference (P < .05) from
corresponding time points across the animal models.
protein and Akt pathway activation [28–31]. For example,
recent work has reported that the obese Zucker kidney
exhibits increased Akt kinase activity and expression of
phosphorylated Akt and mTOR compared to that observed
in lean Zucker animals [32]. Increased circulating amino
acid levels have also been shown to activate mTOR [29, 33].
Whether elevated insulin or amino acids are responsible for
the changes we observe in the present study is unknown.
Further experimentation perhaps employing other methods
of analysis or approaches is necessary to better understand
how changes in the basal phosphorylation of p70S6k, mTOR,
Akt, and GSK-3β may contribute to pathophysiology of
insulin resistance.
4.2. Insulin Resistance is Associated with Alteration in the
Contraction-Induced Activation of Akt Signaling. Previous
work has demonstrated that resistance exercise is capa-
ble of increasing the phosphorylation (activation) of the
p70S6k [11]. Activated p70S6k in turn, is thought to
phosphorylate the ribosomal protein S6 enabling the up-
regulation of 5′ TOP mRNA for encoding translational
machinery and ribosomal proteins [34]. Here we report that
the magnitude and time course of the contraction-induced
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Figure 6: Contraction-induced PTEN (Ser380/Thr382/383) phos-
phorylation is altered with insulin resistance. The basal (con-
trol) and contraction-induced phosphorylation of the GSK-3β in
Plantaris and soleus muscles from lean (LNZ) and obese Zucker
(OSXZ) rats at 0-, 1-, and 3-hours after HFES. Phosphorylation
of PTEN was determined by immunodetection of phosphorylation
on Ser380/Thr382/383. Relative abundance represents ratio of
phosphor to total protein. An asterisk (∗) indicates significant
difference (P < .05) from the control time point within animal
model, and a cross (†) indicates significant difference (P < .05) at
corresponding time points across animal models.
phosphorylation of p70S6k (Thr 389) and p70S6k (Thr
421/Ser 424) appears to be significantly different in obese
Zucker plantaris muscle compared to that observed in the
normal plantaris (Figure 2). To our knowledge, this finding
has not been reported before. The underlying molecular
mechanisms for these alterations remains unclear; however
it is interesting to note that previous reports have suggested
that the insulin-stimulated phosphorylation of p70S6k may
be altered in diabetic rats [35–37]. In the light of these
studies, our data suggest that insulin resistance may affect
how multiple stimuli may regulate the phosphorylation
of p70S6k. Future studies designed to examine if insulin
resistance affects the regulation of p70S6k using different
modes of contraction, different intensities of exercise, or
muscles with different muscle fiber types will no doubt
be useful in furthering our understanding of the effects of
insulin resistance on p70S6k activation.
Similar to previous studies, increased contractile activity
appears to be a strong stimulus to increase the phosphoryla-
tion level of mTOR in nondiabetic muscle [21, 38], however
the magnitude and time course of the contraction-induced
phosphorylation of mTOR was significantly different in
plantaris muscles of the obese (insulin resistant) animals
(Figure 3). This latter finding is consistent with our data
demonstrating that diabetic muscle exhibits a reduced ability
to activate p70S6k following a bout of HFES. Like p70S6k,
mTOR is thought to be involved in the regulating several
components of the translational machinery, and in addition
is thought to be an upstream activator of p70S6k [39].
The factor(s) regulating mTOR are not fully understood.
mTOR has been shown to phosphorylate p70S6k in vitro
and it is thought that this occurs via a mechanism distinct
from the PI3K-dependent pathway [40–42]. Indeed, recent
studies have shown activation of mTOR/p70S6k even in the
absence of Akt activation [42–44]. Although not investigated
here, it has been suggested that phospholipase D (PLD)
may play a key role in regulating mTOR phosphorylation
in response to increased muscle loading [40, 41, 45, 46].
Whether differences in PLD-dependent signaling following
contractile loading exist between the lean and obese Zucker
animals is currently unknown. Nonetheless, our findings are
consistent with the notion that insulin resistance associated
alterations in p70S6k regulation may be due, at least in part,
to defects in the ability of insulin resistant muscle to activate
mTOR following a contractile stimulus.
The precise influence of insulin resistance on Akt reg-
ulation in muscle contraction remains unclear. Akt is a
critical signaling mediator of cellular growth and metabolism
in skeletal muscle [15], that is, translocated to the muscle
membrane when activated by phosphorylation at the Thr308
and Ser 473 residues [47]. Phosphorylation at both these
sites is critical for full activation of Akt. The phosphorylation
of Thr-308 is apparently catalyzed by a 3-phosphoinositide-
dependent protein kinase (PDK1), which is active only in
the presence of phosphatidylinositol-3,4,5-triphosphate and
phosphatidylinositol-3,4-biphosphate [48]. Similar to others
[49–51], we found that a bout of HFES significantly increased
the phosphorylation of both Akt (Thr 308) and Akt (Ser
473) in plantaris muscles of the lean Zucker rats (Figure 4).
Conversely, in the insulin resistant plantaris, HFES appeared
to only increase the phosphorylation of the Akt Ser 473
(Figure 4). The activation of Akt is thought to be a multistep
process and is likely one that involved several proteins [52].
In an effort to determine a possible mechanism for the
alterations in Akt regulation we observed in the obese Zucker
plantaris muscle we next examined the effects of HFES on
the Akt inhibitor PTEN. It is thought that phosphorylation
of PTEN inhibits its phosphatase activity [20]. As expected
from our analysis of how insulin resistance affected the basal
phosophorylation of p70S6k, mTOR and Akt, we found a
higher level of basal PTEN phosphorylation in the obese
Zucker plantaris muscle compared to that observed in lean
animals (Figure 6). Furthermore, with contraction we found
a significant decrease in the phosphorylation of PTEN in the
plantaris muscles obtained from the obese Zucker animals.
Whether this decrease in PTEN phosphorylation we see with
contraction is sufficient to explain the differences in Akt
phosphorylation we observe in the insulin resistant plantaris
is currently unknown. Similarly, it should be noted that
the functional role of PTEN in regulating Akt activation
cannot be accurately assessed in the absence of further study
to evaluate the experimental manipulation of this protein.
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Additional studies perhaps employing strategies designed to
directly inhibit or activate PTEN during HFES may prove
useful in addressing these possibilities.
To explore Akt-related signaling further, we next inves-
tigated the regulation of Akt substrate GSK-3β. Similar to
our findings concerning Akt at Thr 308 phosphorylation, we
failed to find any increase in GSK-3β (Ser 9) phosphorylation
with HFES in the obese Zucker plantaris. The significance
of this finding is currently not known, however it is thought
that the Akt-dependent phosphorylation of GSK-3β leads to
the activation of pathways promoting protein synthesis via
a decreased inhibition of the translational initiation factor
eIF2B [53]. Taken together, these data suggests that insulin
resistance may be associated with alterations in the ability
of fast twitch muscle to activate Akt. Why the regulation of
Akt following HFES may differ in the obese Zucker rat is not
known but this change may be due to defects in the ability
of insulin to activate PI3K signaling in response to increased
muscle loading. Alternatively, it has been postulated that the
degree of Akt activation following contractile activity may be
dependent upon the type of contractile activity, contraction
intensity, and/or the duration of stimulation [21]. Given this
contention, it is possible, that differences in the signaling
response between models could be related to the time points
chosen for evaluation. Similarly, it should be noted that
although the magnitude or time course of contraction-
induced signaling may differ between experimental groups,
the degree of overall activation postexercise was similar in
both groups for most of the Akt signaling protein examined.
As such it is possible that the differences in magnitude
of contraction-induced “activation” we observed may be
simply attributed to differences in the initial level of basal
phosphorylation. A future study employing other time
points or experimental approaches is certainly warranted.
In summary, our data are consistent with the notion
that the insulin resistance may alter contractile signal trans-
duction pathways in skeletal muscle. Whether this finding
alone is able to explain differences in how insulin resistant
muscle respond to exercise regimen is not known and beyond
the scope of this study. Likewise, whether the differences
we observe between models is due to insulin resistance
or to the existence of other abnormalities associated with
the obese phenotype or other characteristics of the obese
Zucker rat model is currently unclear. Given the multitude
of factors thought to be involved in regulating how skeletal
muscle “senses” and “responds” to increased loading stimuli
(e.g., muscle hypoxia, reactive oxygen levels, muscle damage,
local release of growth factors, and cytokines.[54]) it will
be interesting what further research, perhaps using in vitro
contraction paradigms will add to our understanding of
the interplay between insulin resistance and contraction-
induced muscle signaling.
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